S&P 500   4,981.80 (+0.13%)
DOW   38,612.24 (+0.13%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.79%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.00 (+0.53%)
F   12.14 (-0.90%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.07 (+0.30%)
DIS   107.67 (-1.62%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.85 (+2.04%)
S&P 500   4,981.80 (+0.13%)
DOW   38,612.24 (+0.13%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.79%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.00 (+0.53%)
F   12.14 (-0.90%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.07 (+0.30%)
DIS   107.67 (-1.62%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.85 (+2.04%)
S&P 500   4,981.80 (+0.13%)
DOW   38,612.24 (+0.13%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.79%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.00 (+0.53%)
F   12.14 (-0.90%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.07 (+0.30%)
DIS   107.67 (-1.62%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.85 (+2.04%)
S&P 500   4,981.80 (+0.13%)
DOW   38,612.24 (+0.13%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.79%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.00 (+0.53%)
F   12.14 (-0.90%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.07 (+0.30%)
DIS   107.67 (-1.62%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.85 (+2.04%)

Spectrum Pharmaceuticals (SPPI) Short Interest Ratio & Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.

Spectrum Pharmaceuticals Short Interest Data

Current Short Volume
3,330,000 shares
Previous Short Volume
3,210,000 shares
Change Vs. Previous Month
+3.74%
Dollar Volume Sold Short
$3.12 million
Short Interest Ratio / Days to Cover
1.5
Last Record Date
July 15, 2023
Outstanding Shares
205,250,000 shares
Percentage of Shares Shorted
1.62%
Today's Trading Volume
0 shares
Average Trading Volume
1,927,028 shares
Today's Volume Vs. Average
0%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Spectrum Pharmaceuticals ?

Sign up to receive the latest short interest report for Spectrum Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SPPI Short Interest Over Time

SPPI Days to Cover Over Time

SPPI Percentage of Float Shorted Over Time


Spectrum Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/20233,330,000 shares $3.12 million +3.7%N/A1.5 $0.94
6/30/20233,210,000 shares $3.08 million +7.0%N/A1.5 $0.96
6/15/20233,000,000 shares $3.12 million -0.3%N/A1.4 $1.04
5/31/20233,010,000 shares $3.22 million -2.3%N/A1.4 $1.07
5/15/20233,080,000 shares $3.85 million -49.2%N/A1.3 $1.25
4/30/20236,060,000 shares $5.91 million +29.8%N/A2.5 $0.98
4/15/20234,670,000 shares $3.25 million +2.0%N/A2.2 $0.69
3/31/20234,580,000 shares $3.44 million -4.4%N/A2.7 $0.75
3/15/20234,790,000 shares $3.71 million +4.8%N/A2.6 $0.77
2/28/20234,570,000 shares $3.56 million -6.7%N/A2.4 $0.78
2/15/20234,900,000 shares $4.31 million +2.3%N/A2.5 $0.88
1/31/20234,790,000 shares $3.35 million -6.6%N/A2.6 $0.70
1/15/20235,130,000 shares $3.07 million -13.5%N/A2.8 $0.60
12/30/20225,930,000 shares $2.19 million -14.7%N/A3.1 $0.37
12/15/20226,950,000 shares $2.99 million -12.8%N/A3.1 $0.43
11/30/20227,970,000 shares $3.67 million -3.6%N/A1.9 $0.46
11/15/20228,270,000 shares $4.26 million -2.8%N/A1.8 $0.52
10/31/20228,510,000 shares $3.91 million +26.1%N/A1.8 $0.46
10/15/20226,750,000 shares $2.66 million +0.9%N/A1.4 $0.39
9/30/20226,690,000 shares $2.88 million -1.5%N/A1.5 $0.43
9/15/20226,790,000 shares $7.67 million +67.7%N/A1.5 $1.13
8/31/20224,050,000 shares $4.58 million +14.7%N/A1.1 $1.13
8/15/20223,530,000 shares $5.51 million -21.9%2.2%1.5 $1.56
7/31/20224,520,000 shares $3.67 million -18.6%2.8%2.2 $0.81
7/15/20225,550,000 shares $4.63 million -2.6%3.5%2.7 $0.84
6/30/20225,700,000 shares $4.45 million -52.1%3.6%2.6 $0.78
6/15/202211,890,000 shares $9.37 million -6.8%12.1%5 $0.79
5/31/202212,750,000 shares $9.52 million -0.3%N/A5.4 $0.75
5/15/202212,790,000 shares $9.90 million +8.7%N/A5.2 $0.77
4/30/202211,770,000 shares $9.51 million +16.1%7.4%3.9 $0.81
4/15/202210,140,000 shares $9.84 million -7.7%6.4%2.4 $0.97
3/31/202210,990,000 shares $14.18 million +1.9%6.9%2.5 $1.29
3/15/202210,790,000 shares $7.90 million -34.9%6.8%2.1 $0.73
2/28/202216,580,000 shares $11.27 million +2.5%10.5%2.9 $0.68
2/15/202216,180,000 shares $11.78 million +14.0%10.2%2.5 $0.73
1/31/202214,190,000 shares $9.95 million +0.9%9.0%2.3 $0.70
1/15/202214,060,000 shares $15.89 million +10.1%N/A2.9 $1.13
12/31/202112,770,000 shares $16.22 million -45.2%7.9%2.8 $1.27
12/15/202123,280,000 shares $34.92 million +35.5%14.4%6 $1.50
11/30/202117,180,000 shares $27.14 million +6.1%10.6%5.4 $1.58













SPPI Short Interest - Frequently Asked Questions

What is Spectrum Pharmaceuticals' current short interest?

Short interest is the volume of Spectrum Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 3,330,000 shares of SPPI short. Learn More on Spectrum Pharmaceuticals' current short interest.

What is a good short interest ratio for Spectrum Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SPPI shares currently have a short interest ratio of 2.0. Learn More on Spectrum Pharmaceuticals's short interest ratio.

Is Spectrum Pharmaceuticals' short interest increasing or decreasing?

Spectrum Pharmaceuticals saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 3,330,000 shares, an increase of 3.7% from the previous total of 3,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Spectrum Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Spectrum Pharmaceuticals: Merrimack Pharmaceuticals, Inc. (5.33%), XOMA Co. (2.79%), Rigel Pharmaceuticals, Inc. (1.96%), Vanda Pharmaceuticals Inc. (3.98%), Verastem, Inc. (2.82%), Emergent BioSolutions Inc. (20.98%), Eagle Pharmaceuticals, Inc. (7.01%), Lexicon Pharmaceuticals, Inc. (9.40%), OPKO Health, Inc. (23.70%), Werewolf Therapeutics, Inc. (0.96%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($3.75 billion), Charter Communications, Inc. ($3.17 billion), Occidental Petroleum Co. ($2.86 billion), Rivian Automotive, Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.13 billion), Royal Caribbean Cruises Ltd. ($2.05 billion), Palantir Technologies Inc. ($2.04 billion), Extra Space Storage Inc. ($1.98 billion), Enphase Energy, Inc. ($1.66 billion), and Tractor Supply ($1.61 billion). View all of the most shorted stocks.

What does it mean to sell short Spectrum Pharmaceuticals stock?

Short selling SPPI is an investing strategy that aims to generate trading profit from Spectrum Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Spectrum Pharmaceuticals?

A short squeeze for Spectrum Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SPPI, which in turn drives the price of the stock up even further.

How often is Spectrum Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPPI, twice per month. The most recent reporting period available is July, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:SPPI) was last updated on 2/21/2024 by MarketBeat.com Staff